ERNA
Price:
$1.31
Market Cap:
$10.28M
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Industry
Biotechnology
IPO Date
1991-08-29
Stock Exchange
NASDAQ
Ticker
ERNA
According to Ernexa Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.58. This represents a change of 43.41% compared to the average of 1.10 of the last 4 quarters.
The mean historical Current Ratio of Ernexa Therapeutics Inc. over the last ten years is 1.67. The current 1.58 Current Ratio has changed 9.36% with respect to the historical average. Over the past ten years (40 quarters), ERNA's Current Ratio was at its highest in in the March 2022 quarter at 6.82. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
1.67
Median
1.53
Minimum
0.55
Maximum
5.10
Discovering the peaks and valleys of Ernexa Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 820.83%
Maximum Annual Current Ratio = 5.10
Minimum Annual Increase = -64.98%
Minimum Annual Current Ratio = 0.55
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.80 | -45.18% |
| 2023 | 1.46 | -18.30% |
| 2022 | 1.79 | -64.98% |
| 2021 | 5.10 | 820.83% |
| 2020 | 0.55 | -44.35% |
| 2019 | 1.00 | -40.94% |
| 2018 | 1.69 | 88.01% |
| 2017 | 0.90 | -44.12% |
| 2016 | 1.60 | -9.76% |
The current Current Ratio of Ernexa Therapeutics Inc. (ERNA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.35
5-year avg
1.94
10-year avg
1.67
Ernexa Therapeutics Inc.’s Current Ratio is greater than Adaptimmune Therapeutics plc (1.52), less than MapLight Therapeutics, Inc. (0), greater than Lunai Bioworks Inc. (0.04), less than ProMIS Neurosciences, Inc. (1.76), less than Dogwood Therapeutics, Inc. (4.49), less than BiomX Inc. (1.70), greater than Moleculin Biotech, Inc. (1.39), greater than AEON Biopharma, Inc. (0.90), greater than OSR Holdings, Inc. (0.21), less than Aethlon Medical, Inc. (2.49),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.52 | $75.16M | |
| 0 | $14.48M | |
| 0.04 | $23.14M | |
| 1.76 | $9.98M | |
| 4.49 | $11.73M | |
| 1.70 | $7.28M | |
| 1.39 | $9.32M | |
| 0.90 | $8.72M | |
| 0.21 | $17.76M | |
| 2.49 | $10.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ernexa Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ernexa Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Ernexa Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Ernexa Therapeutics Inc. (ERNA)?
What is the highest Current Ratio for Ernexa Therapeutics Inc. (ERNA)?
What is the 3-year average Current Ratio for Ernexa Therapeutics Inc. (ERNA)?
What is the 5-year average Current Ratio for Ernexa Therapeutics Inc. (ERNA)?
How does the current Current Ratio for Ernexa Therapeutics Inc. (ERNA) compare to its historical average?